Who has invested in Immunovant?

Roivant are named among the investors backing Immunovant.

Immunovant Funding: $450M Raised, Post-IPO (2025)

Immunovant funding overview

Immunovant is based in New York, NY. Immunovant has raised $450M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Post-IPO announced in January 2025. The round record for Immunovant runs through 2025; nothing later has been disclosed. Investors on record include Roivant.

Immunovant at a glance

Total raised: $450M
Latest round: Post-IPO
Latest round date: January 2025
Headquarters: New York, NY
Notable investors: Roivant

Frequently asked about Immunovant funding

How much has Immunovant raised?: Immunovant has raised $450M in total disclosed funding across the rounds on record.
Who has invested in Immunovant?: Roivant are named among the investors backing Immunovant.
What was the latest Immunovant funding round?: The most recent disclosed round is a Post-IPO, announced in January 2025.
Where is Immunovant based?: Immunovant is based in New York, NY.
When did Immunovant last raise?: The last disclosed Immunovant round closed in January 2025 at Post-IPO.

Totals shown for Immunovant aggregate every disclosed round on file. To see how that compares, browse the companies in New York and the investors behind them below.

Immunovant Funding: $450M Raised, Post-IPO (2025)

Immunovant funding overview

Immunovant at a glance

Frequently asked about Immunovant funding

Companies related to Immunovant (20)

Browse related funding lists (4)